BY JIM HAMMERAND Hologic (NYSE: HOLX) CFO Karleen Oberton had some tough words for ax-dropping executives following recent layoffs in the...

By Nick Paul Taylor Medtech M&A was down for the second straight year after an explosion of deal-making in 2021, with deal volumes down...

By Nick Paul Taylor Supply chain problems, hospital staffing shortages and other challenges that defined 2022 were largely resolved or...